KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Charles River Laboratories International (CRL) Total Debt (2016 - 2025)

Historic Total Debt for Charles River Laboratories International (CRL) over the last 17 years, with Q3 2025 value amounting to $2.2 billion.

  • Charles River Laboratories International's Total Debt fell 606.88% to $2.2 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $2.2 billion, marking a year-over-year decrease of 606.88%. This contributed to the annual value of $2.2 billion for FY2024, which is 1537.29% down from last year.
  • According to the latest figures from Q3 2025, Charles River Laboratories International's Total Debt is $2.2 billion, which was down 606.88% from $2.3 billion recorded in Q2 2025.
  • Charles River Laboratories International's 5-year Total Debt high stood at $3.0 billion for Q2 2022, and its period low was $2.2 billion during Q3 2025.
  • Its 5-year average for Total Debt is $2.6 billion, with a median of $2.7 billion in 2024.
  • Per our database at Business Quant, Charles River Laboratories International's Total Debt skyrocketed by 4359.11% in 2021 and then tumbled by 1537.29% in 2024.
  • Charles River Laboratories International's Total Debt (Quarter) stood at $2.7 billion in 2021, then rose by 1.54% to $2.7 billion in 2022, then decreased by 2.23% to $2.6 billion in 2023, then decreased by 15.37% to $2.2 billion in 2024, then fell by 2.44% to $2.2 billion in 2025.
  • Its last three reported values are $2.2 billion in Q3 2025, $2.3 billion for Q2 2025, and $2.5 billion during Q1 2025.